Hibero SR
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hibero SR, covering 2024-03-08 to 2024-03-08. Get the full timeline:
Most recent: Clinical Trial Update: A Trial Evaluating the Clinical Efficacy and Safety of Hibero SR (Mirabegron) 50 mg and Ditropan (Oxybutynin Chloride) 10 mg in Children Between 5 and 18 Years With Overactive Bladder (OAB) [Phase 2]